Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 6/20 | 0.37 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.34 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.34 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.34 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.34 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.34 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | GJB2 | P29033 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | TLR2 | O60603 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16772350 | 0.87 | SELP (0.37) | SELPTLR2 | |
| SCHEMBL29827603 | 0.87 | SSTR1 (0.47) | SELPSSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL16980592 | 0.85 | SELP (0.32) | SELPSSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL14477827 | 0.85 | SELP (0.32) | SELPSSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL27054871 | 0.82 | SELP (0.39) | SELPSSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL16367548 | 0.82 | SLC6A2 (0.35) | SELPSSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL17826455 | 0.81 | SSTR1 (0.39) | SELPSSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL27054888 | 0.80 | CETP (0.53) | SELPPTPN1CETP | |
| SCHEMBL13377703 | 0.78 | SSTR1 (0.44) | SELPSSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL27054926 | 0.78 | PTPN1 (0.39) | SELPPTPN1CDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230129118-A1 | PHYTOSPHINGOSINE DERIVATIVES AS ADJUVANTS IN IMMUNE STIMULATION | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230129118-A1 | PHYTOSPHINGOSINE DERIVATIVES AS ADJUVANTS IN IMMUNE STIMULATION | UGCG, PA2G4, IL4 | SELP 830/4885SSTR1 2408/4885SSTR2 3161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.